U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323186) titled 'Evaluation of the NEOmom(R) Gastric Video Capsule for Gastric Cancer Screening' on Dec. 04, 2025.
Brief Summary: Gastric cancer remains a major public health concern, with approximately 6,600 new cases diagnosed each year in France. Despite therapeutic progress, its overall prognosis is still poor: the 5-year survival rate across all stages remains below 30%. This survival is closely linked to the stage at diagnosis. Early-stage gastric cancer has an excellent prognosis, with survival rates above 90%, while advanced-stage disease shows survival below 10%. This dramatic contrast underscores the critical need to develop and implement a...